TIFFANY KAMRATH: Open Payments
NPI 1942586417 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 10 payments from 6 companies in 2025. Trend: 2023 $15 · 2024 $249 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $163 |
| Regeneron Healthcare Solutions, Inc. | 1 | $110 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| GENZYME CORPORATION | 1 | $24 |
| PFIZER INC. | 1 | $16 |
| Incyte Corporation | 1 | $14 |
Products named: TREMFYA, Rhapsido, DUPIXENT, CIBINQO, OPZELURA.
Industry payments across OR — which companies pay providers there.
